Andrew Haydon on Muck Rack

Andrew Haydon

As seen in: Nature, The Guardian, Wiley, Wiley Online Library, MDPI, JAMA (The Journal of the American Medical Association), EClinicalMedicine, The Stage, Journal of Clinical Oncology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Andrew

Contact Andrew, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Prevention of gastric cancer: translating pooled cohort evidence into public health action

|
By Howard Tang, Andrew Haydon, Robert MacInnis
| EClinicalMedicine Verified
Abstract Gastric cancer is a major global health challenge and a leading cause of cancer mortality. Despite therapeutic advances, most patients do not survive beyond one year. In 2024, the U.S. National Cancer Institute (NCI) Think Tank on Advancing Gastric Cancer Prevention developed a gastric cancer prevention roadmap focussed on mitigating Helicobacter pylori infection and improving detection of precursor lesions. For the vast majority, H.
Open in Who Shared Issue with article?

Incidence of Reported Pseudoprogression on 18F‐FDG PET/CT in Metastatic Melanoma Patients Undergoing Immune Checkpoint Inhibitor Immunotherapy

|
By Mark Shackleton, Andrew Haydon, David P Nadebaum, Philip Macilwraith
| Wiley Online Library Verified
Conflicts of Interest The authors declare no conflicts of interest. Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request. References 1, , , et al., “Pembrolizumab versus Ipilimumab in advanced melanoma,” New England Journal of Medicine 372, no. 26 (2015): 2521–2532. 2, , , et al., “Improved Survival With Ipilimumab in Patients With Metastatic Melanoma,” New England Journal of Medicine 363, no.
Open in Who Shared Issue with article?

Characterizing Chronic Cutaneous Immune-Related Adverse Events Following Immune Checkpoint Inhibitors

|
By Rachel Goodman, Rachel Woodford, J. Randall Patrinely, Andrew Haydon
| JAMA (The Journal of the American Medical Association) Verified
[Skip to Navigation] PDF Full Text Share X Facebook Email LinkedIn Cite Permissions March 12, 2025 JAMA Dermatol. Published online March 12, 2025.
Open in Who Shared View Duplicates (10) Issue with article?
See all 31 licensed articles (56 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified